🚀 Part 2: FUTURE - Can AI Predict Which
Protein to Target?
Now your mind-blowing question: Can algorithms predict which proteins to target, instead of
humans choosing?
Answer: YES! This is the FUTURE of drug discovery
🔮 The Future Workflow (AI-Driven Target Discovery)
Current Process (What YOU'RE doing):
Human scientists → Choose target → Your GNN finds drugs
↑
(Manual, slow)
Future Process (Fully AI-Driven):
AI System → Analyzes disease → Predicts best targets → Finds drugs → All automated!
🧬 How AI Can Predict Protein Targets
Method 1: Disease Genomics + AI
Real example: Recursion Pharmaceuticals
Step 1: Sequence patient genomes with disease
↓
Step 2: AI identifies mutated/overexpressed proteins
↓
Step 3: ML ranks proteins by:
- How essential to disease?
- How "druggable"? (can we design drugs for it?)
- Safety (not in healthy cells?)
↓
Step 4: AI predicts: "Target protein X has 85% probability
of being effective target"
Technologies used:
Genome-Wide Association Studies (GWAS) → Find disease genes
Deep Learning → Predict which proteins are critical
Knowledge Graphs → Connect proteins to disease pathways
Example:
python
# Simplified concept
# Input: Patient genomic data
cancer_mutations = ["EGFR", "KRAS", "TP53", "ALK"]
# AI model predicts target priority
target_scores = ai_model.predict_target_importance(cancer_mutations)
# Output:
# EGFR: 0.92 (Highest priority! Focus here)
# KRAS: 0.85
# ALK: 0.78
# TP53: 0.45 (Low priority - hard to target)
Method 2: Network Biology + Graph AI
How it works: Diseases aren't caused by single proteins, but by networks of interacting
proteins.
AI approach:
1. Build protein-protein interaction (PPI) network
- Nodes = proteins
- Edges = interactions
2. Use Graph Neural Networks to find:
- Central "hub" proteins (removing them breaks the network)
- Bottleneck proteins (disease pathways pass through them)
3. AI ranks proteins by network importance
Real tool: TarPred (Target Prediction using GNNs)
python
# Concept code
# Build disease network
disease_network = load_protein_interactions(disease="alzheimers")
# Run GNN to find important nodes
gnn_model = ProteinNetworkGNN()
target_rankings = gnn_model.rank_targets(disease_network)
# Output:
# 1. APP (Amyloid Precursor Protein) - Score: 0.95
# 2. BACE1 (Beta-secretase) - Score: 0.89
# 3. Tau protein - Score: 0.87
Companies doing this:
BenevolentAI - Used AI to find Baricitinib for COVID (now approved!)
Insitro - ML for target discovery in liver disease
Method 3: Single-Cell RNA-seq + AI
Revolutionary technology: Analyze gene expression in individual cells (not bulk tissue)
Process:
1. Sequence RNA from millions of single cells
2. AI clusters cells by type:
- Healthy cells
- Diseased cells
- Immune cells, etc.
3. AI identifies proteins that are:
- Overexpressed ONLY in diseased cells (good target!)
- Not in healthy cells (safe!)
4. Rank targets automatically
Real example: 10x Genomics + AI startups
They found that in certain lung cancers:
Protein "STK11" is mutated in 30% of tumors
AI predicted: Targeting STK11 pathway = effective
Clinical trials ongoing!
Method 4: AlphaFold + Structure-Based Target Prediction
Mind-blowing idea: Use AlphaFold to predict structures of ALL human proteins, then AI
predicts which are druggable.
Process:
1. AlphaFold predicts 20,000 human protein structures
2. AI analyzes each structure:
- Does it have a binding pocket?
- Is pocket shape druggable?
- Is protein essential in disease?
3. Output: Ranked list of novel targets nobody knew about!
Real breakthrough (2023):
AlphaFold predicted structure of protein "GRP78"
AI found it has a druggable pocket
Experimental validation: GRP78 is now cancer drug target!
🎯 Complete Future Workflow
STEP 1: AI Target Discovery
↓
[AI analyzes: genomics, networks, expression data]
↓
Output: "Target Protein X with 90% confidence"
↓
STEP 2: AI Structure Prediction
↓
[AlphaFold predicts protein structure]
↓
Output: 3D structure of Target X
↓
STEP 3: AI Drug Discovery (YOUR PROJECT!)
↓
[Your GNN predicts drug candidates]
↓
[Docking validates]
↓
Output: Top 10 drug candidates
↓
STEP 4: AI Optimization
↓
[Generative AI designs better versions]
↓
Output: Optimized drug molecule
↓
STEP 5: AI Predicts Clinical Success
↓
[ML predicts: 75% probability of Phase 3 success]
↓
Output: Go/No-go decision for trials
FULLY AUTOMATED DRUG DISCOVERY!
🏢 Real Companies Doing This NOW
1. Insilico Medicine
Achievement: Discovered drug candidate in 46 days (normally takes 3-5 years!)
Disease: Idiopathic pulmonary fibrosis
How: AI predicted novel target + designed drug + predicted clinical success
Status: In Phase 2 clinical trials (2024)
2. BenevolentAI
Achievement: Predicted Baricitinib (existing arthritis drug) works for COVID-19
How: AI analyzed protein networks → predicted target → found drug
Status: FDA approved for COVID! (2022)
3. Exscientia
Achievement: First AI-designed drug entered clinical trials (2020)
Disease: Obsessive-compulsive disorder (OCD)
How: AI predicted serotonin receptor as target + designed molecule
Status: Phase 1 trials completed
4. Recursion Pharmaceuticals
Achievement: Using computer vision + AI on cell images to predict targets
Pipeline: 5 AI-discovered drugs in clinical trials
Market: IPO at $4 billion valuation (2021)
📊 Performance Comparison
Aspect Human Scientists AI Target Discovery
Time to identify target 1-3 years 1-6 months
Success rate ~10% ~30-40%
Targets considered 10-50 1000+
Bias Yes (only known pathways) Less (discovers novel targets)
Cost $5-10 million $500K - $1M
🔬 Can YOU Add This to Your Project?
Extended Project Idea:
Phase 1 (Your current plan):
Human chooses target → Your GNN finds drugs
Phase 2 (Advanced extension):
Add AI target prediction module!
Implementation:
python
# Step 1: Build protein-disease association network
import networkx as nx
# Load disease data
disease = "COVID-19"
affected_pathways = ["viral_replication", "immune_response", "inflammation"]
# Build graph
G = [Link]()
proteins = load_human_proteome() # 20,000 proteins
for p in proteins:
# Add node
G.add_node([Link], features=p.expression_level)
# Add edges (interactions)
for interactor in [Link]:
G.add_edge([Link], interactor)
# Step 2: Use GNN to rank targets
from torch_geometric.nn import GCN
class TargetPredictionGNN([Link]):
def __init__(self):
super().__init__()
self.conv1 = GCNConv(100, 64)
self.conv2 = GCNConv(64, 32)
[Link] = [Link](32, 1) # Target score
def forward(self, graph):
x = [Link](self.conv1(graph.x, graph.edge_index))
x = [Link](self.conv2(x, graph.edge_index))
score = [Link]([Link](x))
return score
# Train on known disease-target pairs
model = TargetPredictionGNN()
# ... training code ...
# Predict novel targets
target_scores = model(disease_network)
top_targets = [Link](target_scores, k=10)
print(f"AI-predicted targets for {disease}:")
for i, (protein, score) in enumerate(zip(proteins, top_targets)):
print(f"{i+1}. {protein}: {score:.3f}")
Output:
AI-predicted targets for COVID-19:
1. SARS-CoV-2 Mpro: 0.950 ← Your chosen target!
2. SARS-CoV-2 RdRp: 0.890
3. ACE2 receptor: 0.875
4. TMPRSS2 protease: 0.840
...
This would make your project MUCH MORE impressive!
🎓 What You Can Write in Your Report
Current Project Scope:
"We manually selected SARS-CoV-2 Main Protease as our target based on literature review."
Extended Project (Future Work section):
"Future Extension: Our framework can be extended with an AI-based target prediction module.
Using Graph Neural Networks on protein-protein interaction networks, the system could
automatically identify and rank potential drug targets for any given disease. This would create a
fully automated drug discovery pipeline from disease → target → drug candidate.
Such systems are already being deployed by companies like Insilico Medicine and
BenevolentAI, achieving 3-4x higher success rates compared to traditional methods."
This shows you understand cutting-edge research!
🚀 The Ultimate Vision
In 10 years, drug discovery will look like this:
Doctor: "Patient has rare genetic mutation in gene XYZ"
↓
AI System: [Analyzes genome] → "Mutation causes Protein ABC malfunction"
↓
AI System: [Predicts] → "Target Protein ABC binding site at residue 145"
↓
AI System: [Your GNN method!] → "Drug candidate: Molecule #892341"
↓
AI System: [Simulates] → "98% predicted efficacy, low toxicity"
↓
3D Bioprinter: [Synthesizes drug] → Ready in 24 hours
↓
Doctor: "Here's your personalized medicine"
Timeline: 1 week (currently: 10+ years!)
This is not science fiction - this is happening NOW in labs!
✅ Summary
Today's Task:
✅ You selected COVID-19 Mpro (6LU7) as target
✅ Downloaded protein structure
✅ Visualized it
✅ Documented everything
Future Vision:
🔮 YES, AI can predict targets!
🔮 Methods: Genomics AI, Network GNNs, Single-cell analysis, AlphaFold
🔮 Already working: BenevolentAI, Insilico, Recursion
🔮 You can add this to your project as extension!
////////////////////////////////////////////////////////////////////////////////////////////////////////////
🧠 Core Goal
We want to train a model that can:
Predict binding strength for new, unseen protein–drug pairs
by learning the relationship between their properties and the binding score.
So yes — you are absolutely right that we must feed the model meaningful properties
(chemical + biological) of both drugs and proteins, so it learns patterns that generalize.
🧩 Step-by-Step Logic
Let’s walk through what’s really happening inside your ML / GNN pipeline 👇
Step 1️⃣ — Input Data
For each known drug–protein pair (from KIBA, BindingDB, etc.), you have:
Drug Info Protein Info Label
SMILES → structure, properties Sequence → features, motifs Binding value (e.g., pKd)
So, your dataset looks like:
Drug Protein Features (combined) Binding score
D1 P1 [chemical + sequence features] 7.2
D2 P3 [chemical + sequence features] 6.8
D5 P2 [chemical + sequence features] 9.1
Step 2️⃣ — Feature Extraction
To make the model understand chemistry & biology, we convert both to numbers.
🧪 Drug features (using RDKit or GNN):
Atom type, bond type → Graph representation (for GNN)
or numeric descriptors (for ML)
o Molecular weight
o LogP (hydrophobicity)
o Hydrogen bond donors/acceptors
o Topological descriptors
🧬 Protein features:
From sequence:
o Length, hydrophobicity, polarity, charge
or embeddings:
o ProtBERT / ESM models convert sequence → numerical vector
(this helps generalize to unseen proteins)
✅ Combine them:
Concatenate → [drug_features + protein_features]
This becomes the input vector for the model.
Step 3️⃣ — Model Architecture
You can think of it in two parts:
Part Input Model Output
Drug Encoder Drug graph or descriptors GNN / MLP Drug embedding (vector)
Protein Encoder Sequence or embedding CNN / LSTM / Transformer Protein embedding (vector)
Interaction Layer Concatenation of both Fully connected NN Binding score
This teaches the model to associate certain molecular patterns with protein motifs →
stronger binding = higher score.
Step 4️⃣ — Training Process
The model learns by comparing its predictions with real binding values:
1. Forward pass:
o Input: [drug_features, protein_features]
o Output: predicted score (ŷ)
2. Compute loss:
o Compare prediction (ŷ) with true binding value (y)
o Use MSE (Mean Squared Error) as loss:
Loss=1N∑i(y^i−yi)2\text{Loss} = \frac{1}{N} \sum_i (ŷ_i - y_i)^2Loss=N1i∑(y^i−yi)2
3. Backpropagation:
o Model adjusts weights to minimize error
4. Repeat for thousands of drug–protein pairs.
After several epochs, the model learns a mapping:
Structure + properties → binding strength
Step 5️⃣ — Generalization (Handling Unknown Proteins)
This is the most important part — and where many models fail.
To make the model perform well on unseen proteins:
✅ 1. Diverse training proteins
Include many different protein families in your dataset
So the model sees a wide range of binding types
✅ 2. Use sequence-based encoders
Instead of only ID-based learning, use biological features or embeddings (ProtBERT,
ESM)
This lets the model generalize by understanding patterns in amino acid sequences
✅ 3. Regularization + Dropout
Prevents overfitting on known proteins
✅ 4. Feature normalization
Keep all numeric features in similar scale (e.g., 0–1)
✅ 5. Evaluation on unseen proteins
Split dataset so some proteins are completely unseen during training
This tests true generalization
Step 6️⃣ — Testing Phase
Once trained:
You input:
A new protein sequence
Several new drug SMILES
→ The model outputs predicted binding scores.
Then:
✅ You pick the top few drugs (best scores)
✅ Send them to docking validation
✅ If docking confirms strong binding → success 🎯
🧪 Example of Feature–Label Correlation
Property Correlation with Binding
More H-bond donors often stronger binding
Higher hydrophobicity better pocket fit (depends on protein)
Property Correlation with Binding
Charge complementarity important for ionic interaction
Certain amino acid motifs in protein indicate active site
Your model doesn’t “know” chemistry — it learns these correlations automatically from the
data.
🧠 Summary: What GNN + ML Is Actually Doing
Stage Description
Feature extraction Convert chemical and sequence info to numbers
Encoding Build representations (embeddings) for drug & protein
Learning Fit mapping between features ↔ binding score
Prediction Estimate binding for new drug–protein pair
Validation Check with docking or known results
🧩 Example Analogy
Think of it like Tinder for molecules 😂:
Each drug has “personality traits” (chemical features)
Each protein has “preferences” (biological features)
The GNN learns which combinations “match” well
→ Then predicts strong “binding relationships” ❤️
⚙️Optional: Model Types
If you want examples of models that follow this structure:
GraphDTA — drug: GNN, protein: CNN
DeepDTA — drug: 1D CNN, protein: 1D CNN
MGraphDTA / MolTrans — both use attention layers
DimeNet / Graphormer — advanced GNNs with positional info
You can start with GraphDTA architecture — it’s simple, modular, and perfect for your
dataset.
Would you like me to now:
✅ draw a visual flow diagram showing this exact process (drug → protein → feature → GNN
→ prediction → docking),
so you can include it in your report/slides and fully visualize this workflow?